Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.
Zaballa ME, Perez-Saez J, de Mestral C, Pullen N, Lamour J, Turelli P, Raclot C, Baysson H, Pennacchio F, Villers J, Duc J, Richard V, Dumont R, Semaani C, Loizeau AJ, Graindorge C, Lorthe E, Balavoine JF, Pittet D, Schibler M, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe KM, Kaiser L, Trono D, Stringhini S, Guessous I; Specchio-COVID19 study group. Zaballa ME, et al. Lancet Reg Health Eur. 2023 Jan;24:100547. doi: 10.1016/j.lanepe.2022.100547. Epub 2022 Dec 1. Lancet Reg Health Eur. 2023. PMID: 36474728 Free PMC article.
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.
West EA, Anker D, Amati R, Richard A, Wisniak A, Butty A, Albanese E, Bochud M, Chiolero A, Crivelli L, Cullati S, d'Acremont V, Epure AM, Fehr J, Flahault A, Fornerod L, Frank I, Frei A, Michel G, Gonseth S, Guessous I, Imboden M, Kahlert CR, Kaufmann L, Kohler P, Mösli N, Paris D, Probst-Hensch N, Rodondi N, Stringhini S, Vermes T, Vollrath F, Puhan MA; Corona Immunitas Research Group. West EA, et al. Int J Public Health. 2020 Dec;65(9):1529-1548. doi: 10.1007/s00038-020-01494-0. Epub 2020 Oct 24. Int J Public Health. 2020. PMID: 33098441 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak.
Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, de Mestral C, Picazio A, Pennacchio F, Wisniak A, Richard A, Baysson H, Loizeau A, Balavoine JF, Trono D, Pittet D, Posfay-Barbe K, Flahault A, Chappuis F, Kherad O, Vuilleumier N, Kaiser L, Azman AS, Guessous I; Specchio-COVID19 Study Group. Stringhini S, et al. Among authors: zaballa me. Lancet Infect Dis. 2021 May;21(5):600-601. doi: 10.1016/S1473-3099(21)00054-2. Epub 2021 Feb 1. Lancet Infect Dis. 2021. PMID: 33539733 Free PMC article. No abstract available.
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S; SEROCoV-POP study group. Leidi A, et al. Among authors: zaballa me. Clin Infect Dis. 2022 Mar 1;74(4):622-629. doi: 10.1093/cid/ciab495. Clin Infect Dis. 2022. PMID: 34043763 Free PMC article.
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
Stringhini S, Zaballa ME, Pullen N, de Mestral C, Perez-Saez J, Dumont R, Picazio A, Pennacchio F, Dibner Y, Yerly S, Baysson H, Vuilleumier N, Balavoine JF, Bachmann D, Trono D, Pittet D, Chappuis F, Kherad O, Kaiser L, Azman AS; SEROCoV-WORK + Study Group; Guessous I. Stringhini S, et al. Among authors: zaballa me. Nat Commun. 2021 Jun 8;12(1):3455. doi: 10.1038/s41467-021-23796-4. Nat Commun. 2021. PMID: 34103517 Free PMC article.
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance.
Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS; Specchio-COVID19 Study Group. Perez-Saez J, et al. Among authors: zaballa me. Clin Microbiol Infect. 2021 Nov;27(11):1695.e7-1695.e12. doi: 10.1016/j.cmi.2021.06.040. Epub 2021 Jul 7. Clin Microbiol Infect. 2021. PMID: 34245905 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau AJ, Lamour J, Pennacchio F, Wisniak A, Dumont R, Baysson H, Richard V, Lorthe E, Semaani C, Balavoine JF, Pittet D, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe K, Kaiser L, Guessous I; Specchio-COVID19 study group. Stringhini S, et al. Among authors: zaballa me. Euro Surveill. 2021 Oct;26(43):2100830. doi: 10.2807/1560-7917.ES.2021.26.43.2100830. Euro Surveill. 2021. PMID: 34713799 Free PMC article.
Perceptions of vaccination certificates among the general population in Geneva, Switzerland.
Nehme M, Baysson H, Pullen N, Wisniak A, Pennacchio F, Zaballa ME, Fargnoli V, Kaiser L, Hurst S, Burton-Jeangros C, Stringhini S, Guessous I; Specchio-COVID19 study group. Nehme M, et al. Among authors: zaballa me. Swiss Med Wkly. 2021 Nov 29;151:w30079. doi: 10.4414/smw.2021.w30079. eCollection 2021 Nov 22. Swiss Med Wkly. 2021. PMID: 34846113 Free article.
41 results